Quote & Headlines
StockTalk
CYTC is defunct.
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Cancer Stocks Finish a Tough QuarterAlan Brochstein • Mon, Oct 1, 2007
-
Cancer Stocks: Tracking the MarketAlan Brochstein • Mon, Jul 9, 2007
-
Cancer Stocks: The Bleeding SlowsAlan Brochstein • Mon, Jul 2, 2007
-
Jim Cramer's Mad Money Lightning Round Picks, 6/18/07SA Editor Miriam Metzinger • Mon, Jun 18, 2007
-
In Swallowing Cytyc, Hologic Paints Too Rosy A PictureGeorge Gutowski • Tue, May 22, 2007
-
Hologic Acquiring Cytyc for $6.2 BillionSA Editor Judith Levy • Mon, May 21, 2007
-
Biotech Day In Review: Merger MondayCentient Biotech Investor • Tue, Feb 13, 2007
-
Cytyc Buys New Device; Q3 Results PromisingH.S. Ayoub • Thu, Oct 26, 2006
To learn more about Seeking Alpha Pro, click here.
-
Cytyc Buys New Device; Q3 Results PromisingH.S. Ayoub • Thu, Oct 26, 2006
-
Cancer Stocks Finish a Tough QuarterAlan Brochstein • Mon, Oct 1, 2007
-
Cancer Stocks: Tracking the MarketAlan Brochstein • Mon, Jul 9, 2007
-
Cancer Stocks: The Bleeding SlowsAlan Brochstein • Mon, Jul 2, 2007
-
Jim Cramer's Mad Money Lightning Round Picks, 6/18/07SA Editor Miriam Metzinger • Mon, Jun 18, 2007
-
In Swallowing Cytyc, Hologic Paints Too Rosy A PictureGeorge Gutowski • Tue, May 22, 2007
-
Hologic Acquiring Cytyc for $6.2 BillionSA Editor Judith Levy • Mon, May 21, 2007
-
Biotech Day In Review: Merger MondayCentient Biotech Investor • Tue, Feb 13, 2007
There are no Transcripts on CYTC.
There are no News articles on CYTC.
We currently have no instablog posts on this stock.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.